Treatment of length dependent neuropathy

Details for Australian Patent Application No. 2010214659 (hide)

Owner Arcion Therapeutics, Inc.

Inventors Campbell, James N.

Agent FB Rice

Pub. Number AU-B-2010214659

Parent 2006311580

Filing date 25 August 2010

Wipo publication date 16 September 2010

Acceptance publication date 2 February 2012

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4168 (2006.01)

A61K 31/425 (2006.01) - Thiazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

9 September 2010 Complete Application Filed

16 September 2010 Application Open to Public Inspection

  Published as AU-B-2010214659

2 February 2012 Application Accepted

  Published as AU-B-2010214659

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010214660-Freight container

2010214658-Compact Oronasal Patient Interface